PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study — Neutral

PCRX   Zacks Investment Research — April 04, 2025

Pacira doses the first patient in the phase II ASCEND study of PCRX-201 gene therapy for OA of the knee.

image for news PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study

4 Stocks Trading Near 52-Week High With More Upside Potential — Positive

FMS  TAP  TGI  THG   Zacks Investment Research — April 04, 2025

Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.

image for news 4 Stocks Trading Near 52-Week High With More Upside Potential

Is the Options Market Predicting a Spike in Leidos (LDOS) Stock? — Neutral

LDOS   Zacks Investment Research — April 04, 2025

Investors need to pay close attention to Leidos (LDOS) stock based on the movements in the options market lately.

image for news Is the Options Market Predicting a Spike in Leidos (LDOS) Stock?

Should Value Investors Buy BGC Group, Inc. (BGC) Stock? — Positive

BGC   Zacks Investment Research — April 04, 2025

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Should Value Investors Buy BGC Group, Inc. (BGC) Stock?

Are Investors Undervaluing Primoris Services (PRIM) Right Now? — Positive

PRIM   Zacks Investment Research — April 04, 2025

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Are Investors Undervaluing Primoris Services (PRIM) Right Now?

Wall Street Analysts Think RTX (RTX) Is a Good Investment: Is It? — Neutral

RTX   Zacks Investment Research — April 04, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Wall Street Analysts Think RTX (RTX) Is a Good Investment: Is It?

Is Commvault (CVLT) a Buy as Wall Street Analysts Look Optimistic? — Positive

CVLT   Zacks Investment Research — April 04, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Is Commvault (CVLT) a Buy as Wall Street Analysts Look Optimistic?

Is It Worth Investing in Twilio (TWLO) Based on Wall Street's Bullish Views? — Positive

TWLO   Zacks Investment Research — April 04, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Is It Worth Investing in Twilio (TWLO) Based on Wall Street's Bullish Views?

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? — Neutral

ABT   Zacks Investment Research — April 04, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

Wall Street Bulls Look Optimistic About QuickLogic (QUIK): Should You Buy? — Positive

QUIK   Zacks Investment Research — April 04, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Bulls Look Optimistic About QuickLogic (QUIK): Should You Buy?

Brokers Suggest Investing in Duke Energy (DUK): Read This Before Placing a Bet — Neutral

DUK   Zacks Investment Research — April 04, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Brokers Suggest Investing in Duke Energy (DUK): Read This Before Placing a Bet

Brokers Suggest Investing in Archrock Inc. (AROC): Read This Before Placing a Bet — Neutral

AROC   Zacks Investment Research — April 04, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Brokers Suggest Investing in Archrock Inc. (AROC): Read This Before Placing a Bet

Wall Street Bulls Look Optimistic About Emerson Electric (EMR): Should You Buy? — Positive

EMR   Zacks Investment Research — April 04, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Bulls Look Optimistic About Emerson Electric (EMR): Should You Buy?

Owens Corning (OC) Is Considered a Good Investment by Brokers: Is That True? — Neutral

OC   Zacks Investment Research — April 04, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Owens Corning (OC) Is Considered a Good Investment by Brokers: Is That True?

Is Toll Brothers (TOL) a Buy as Wall Street Analysts Look Optimistic? — Positive

TOL   Zacks Investment Research — April 04, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Is Toll Brothers (TOL) a Buy as Wall Street Analysts Look Optimistic?

This Investing Move Can Help Your Portfolio Amid Tariff News — Neutral

TCAF   ETF Trends — April 04, 2025

With tariffs implemented this week after much discussion, markets took a severe tumble. Tariff news saw major indexes like the S&P 500 drop significantly.

image for news This Investing Move Can Help Your Portfolio Amid Tariff News

AKRON, Ohio , April 4, 2025 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) announced today that Nick Pearson has been named Vice President, Federal Government Affairs, effective April 7. In this role, Pearson will oversee the company's Washington, D.C.

image for news FirstEnergy Names Nick Pearson Vice President, Federal Government Affairs

WINTER HAVEN, Fla. , April 4, 2025 /PRNewswire/ -- SouthState Corporation (NYSE: SSB) ("SouthState") announced today that it will release first quarter 2025 earnings results on Thursday, April 24, 2025, after the market closes.

image for news SouthState Corporation to Announce Quarterly Earnings Results on Thursday, April 24, 2025

BOSTON , April 4, 2025 /PRNewswire/ -- The Berkshire Hills Bancorp, Inc. (NYSE: BHLB) first quarter 2025 earnings release and conference call are scheduled as follows: Earnings Release: Thursday, April 24, 2025, at approximately 7:30 a.m. (Eastern) Conference Call: Thursday, April 24, 2025, at 9:00 a.m.

image for news Berkshire Hills Announces First Quarter 2025 Earnings Release and Conference Call Schedule

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or the "Company") (NYSE:MRK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK